TSHA - Taysha Gene Therapies Inc.

$4.43 as of 2026-10-07 · Healthcare · Biotechnology · Stock

TSHA (Taysha Gene Therapies Inc.) is the #1889 most-held security of 3,193 tracked on Upside Invest, held by 1 retail investor (0% of tracked portfolios), at an average allocation of 1.5% of their portfolio.

• Popularity rank: #1889 of 3,193
• Holders on Upside: 1 retail investor
• Average allocation: 1.5%
• Average holder gain/loss: -1.1%
• 30-day trading activity: 0 buys / 0 sells
• Market cap: $908M

Related Healthcare securities: LLY, UNH, JNJ, MRK, HIMS

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.